Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-17

Clinical Trial Update: Arnica and the Management of Pain in Acute Musculoskeletal Extremity Injuries [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Arnica in managing pain from acute musculoskeletal extremity injuries (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arnica (Arnica montana)

Snippet

Sponsor: Children's Hospitals and Clinics of Minnesota | Conditions: Pain, Muscle, Pain, Acute | Phase 2, Phase 3 | Status: UNKNOWN